On June 13, the Supreme Court of the United States (SCOTUS) ruled unanimously to protect access to mifepristone, a drug commonly used for medical abortions. The Court’s decision reversed a lower court’s decision that would have restricted access to the drug which is used in roughly 60% of abortions in the U.S. Writing for the Court, Justice Kavanaugh said that the doctor’s suing to restrict access did not have any standing to sue since the Food and Drug Administration’s relaxed regulations did not require physicians to prescribe or administer the drug. This is not the end of the legal battles over the drug. The Court’s decision leaves the potential for a lawsuit brought by three states – Kansas, Missouri and Idaho – to bring other challenges before a judge in Texas known for his antiabortion stance.